SCHEMBL9970890

SCHEMBL9970890

Cc1cnn(-c2cc(N(C)C)ncn2)c1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP2C19 P33261 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 5/20 0.35
LMNA P02545 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
RECQL P46063 1/20 0.34
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
TP53 P04637 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
SMPD3 Q9NY59 1/20 0.32
ELOVL1 Q9BW60 1/20 0.31
PIM1 P11309 1/20 0.30
PIM3 Q86V86 1/20 0.30
PIM2 Q9P1W9 1/20 0.30
HTT P42858 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21177620 0.82 CYP1A2 (0.38) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4
SCHEMBL9970942 0.76 MAPT (0.46) CYP1A2ALDH1A1CYP2C19HSD17B10CYP2D6
SCHEMBL12051560 0.69 SOS1 (0.35) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4
SCHEMBL21177942 0.68 CYP1A2 (0.36) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4
SCHEMBL21177290 0.67 CYP1A2 (0.36) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4
SCHEMBL15711332 0.66 TSHR (0.44) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4
SCHEMBL7717522 0.65 CYP1A2 (0.50) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4
SCHEMBL27912703 0.65 MAPT (0.39) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4
SCHEMBL2516413 0.65 CYP1A2 (0.43) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4
Hydrochloric Acid SCHEMBL27685777 0.63 CYP1A2 (0.42) CYP1A2ALDH1A1CYP2C19HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202876-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2012-06-19 US disclosed
US-20100029605-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029605-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS FYN, ABL2, LCK CYP1A2 4008/4885ALDH1A1 3998/4885CYP2C19 4243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.